128 related articles for article (PubMed ID: 21131163)
1. Curative surgical treatment after inefficient long-acting somatostatin analogues therapy of a tumor-induced osteomalacia.
Mékinian A; Ladsous M; Balavoine AS; Carnaille B; Aubert S; Soudan B; Wémeau JL
Presse Med; 2011 Mar; 40(3):309-13. PubMed ID: 21131163
[No Abstract] [Full Text] [Related]
2. Localisation of mesenchymal tumours by somatostatin receptor imaging.
Jan de Beur SM; Streeten EA; Civelek AC; McCarthy EF; Uribe L; Marx SJ; Onobrakpeya O; Raisz LG; Watts NB; Sharon M; Levine MA
Lancet; 2002 Mar; 359(9308):761-3. PubMed ID: 11888589
[TBL] [Abstract][Full Text] [Related]
3. Positive somatostatin receptor imaging does not predict somatostatin analogue efficacy in tumor-induced osteomalacia.
Łebek-Szatańska A; Papierska L; Marcinowska-Suchowierska E; Nowak KM; Zgliczyński W; Misiorowski W
Pol Arch Intern Med; 2018 Sep; 128(9):554-555. PubMed ID: 30141426
[No Abstract] [Full Text] [Related]
4. [Somatostatin receptor scintigraphy in a patient with metastatic hemangiopericytoma].
Müller V; Klutmann S; Clausen M
Nuklearmedizin; 2003 Jun; 42(3):N13-4. PubMed ID: 12848152
[No Abstract] [Full Text] [Related]
5. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in carcinoid pathogenesis, diagnosis and management.
Ganim RB; Norton JA
Surg Oncol; 2000 Dec; 9(4):173-9. PubMed ID: 11476988
[TBL] [Abstract][Full Text] [Related]
7. Nasal hemangiopericytoma presenting with oncogenic osteomalasia: A case report and literature review.
Gökyer A; Sayın S; Küçükarda A; Çelik M; Güldiken S; Çiçin İ
Curr Probl Cancer; 2021 Jun; 45(3):100704. PubMed ID: 33446319
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin analogues in diagnosis and management of neuroendocrine tumors].
Nalewajka-Kołodziejczak J
Pol Arch Med Wewn; 1999 Feb; 101(2):159-64. PubMed ID: 10723232
[No Abstract] [Full Text] [Related]
9. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
[TBL] [Abstract][Full Text] [Related]
10. Oncogenous osteomalacia.
Ghosh S; Sinha R; Bandyopadhyay R; Malhotra M
J Cancer Res Ther; 2009; 5(3):210-2. PubMed ID: 19841566
[TBL] [Abstract][Full Text] [Related]
11. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
13. Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan.
Auethavekiat P; Roberts JR; Biega TJ; Toney MO; Christensen RS; Belnap CM; Berenberg JL
J Clin Oncol; 2005 May; 23(15):3626-8. PubMed ID: 15908675
[No Abstract] [Full Text] [Related]
14. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Sandhu FA; Martuza RL
J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
[TBL] [Abstract][Full Text] [Related]
15. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
Longo F; De Filippis L; Zivi A; Vitolo D; Del Signore E; Gori B; Diso D; Anile M; Venuta F; De Giacomo T; Coloni CF
Am J Clin Oncol; 2012 Apr; 35(2):105-9. PubMed ID: 21325939
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin analogue (octreotide)].
Sano K; Makuuchi M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():674-7. PubMed ID: 11762035
[No Abstract] [Full Text] [Related]
18. [Tumor-induced osteomalacia caused by nasal hemangiopericytoma: a case report].
Huang PY; Li YZ; Yang XM; Yu BQ; Guo L; Guo ZT; Li SS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):615-617. PubMed ID: 31434378
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
Cebon J; Findlay M; Hargreaves C; Stockler M; Thompson P; Boyer M; Roberts S; Poon A; Scott AM; Kalff V; Garas G; Dowling A; Crawford D; Ring J; Basser R; Strickland A; Macdonald G; Green M; Nowak A; Dickman B; Dhillon H; Gebski V;
Br J Cancer; 2006 Oct; 95(7):853-61. PubMed ID: 16953241
[TBL] [Abstract][Full Text] [Related]
20. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
Wolin EM; Jarzab B; Eriksson B; Walter T; Toumpanakis C; Morse MA; Tomassetti P; Weber MM; Fogelman DR; Ramage J; Poon D; Gadbaw B; Li J; Pasieka JL; Mahamat A; Swahn F; Newell-Price J; Mansoor W; Öberg K
Drug Des Devel Ther; 2015; 9():5075-86. PubMed ID: 26366058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]